Aileron Therapeutics Alpha and Beta Analysis
| ALRNDelisted Stock | USD 2.11 0.15 7.65% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Aileron Therapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in Aileron Therapeutics over a specified time horizon. Remember, high Aileron Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Aileron Therapeutics' market risk premium analysis include:
Beta 0.45 | Alpha (0.57) | Risk 5.73 | Sharpe Ratio (0.21) | Expected Return (1.19) |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Aileron |
Aileron Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Aileron Therapeutics market risk premium is the additional return an investor will receive from holding Aileron Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Aileron Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Aileron Therapeutics' performance over market.| α | -0.57 | β | 0.45 |
Aileron Therapeutics Fundamentals Vs Peers
Comparing Aileron Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Aileron Therapeutics' direct or indirect competition across all of the common fundamentals between Aileron Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Aileron Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Aileron Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Aileron Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Aileron Therapeutics to competition |
| Fundamentals | Aileron Therapeutics | Peer Average |
| Return On Equity | -0.44 | -0.31 |
| Return On Asset | -0.26 | -0.14 |
| Current Valuation | 28.45 M | 16.62 B |
| Shares Outstanding | 21.67 M | 571.82 M |
| Shares Owned By Insiders | 0.60 % | 10.09 % |
| Shares Owned By Institutions | 28.47 % | 39.21 % |
| Number Of Shares Shorted | 141.21 K | 4.71 M |
Aileron Therapeutics Opportunities
Aileron Therapeutics Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | KCK LTD. Adjusts Stake in NeuroPace Inc | 10/25/2024 |
2 | Disposition of 6291 shares by University Of Texastexas Am Investment Management Co of Aileron Therapeutics at 3.3 subject to Rule 16b-3 | 11/07/2024 |
3 | Aileron Therapeutics Investigational Drug Shows Encouraging Action In Lung Fibrosis | 11/13/2024 |
4 | Disposition of 337 shares by University Of Texastexas Am Investment Management Co of Aileron Therapeutics at 4.28 subject to Rule 16b-3 | 11/29/2024 |
5 | Acquisition by James Windsor of 161 shares of Aileron Therapeutics at 2.25 subject to Rule 16b-3 | 12/05/2024 |
6 | Aileron Therapeutics Stock Plummets Amidst Market Volatility | 12/17/2024 |
7 | Aileron Therapeutics announces rebranding to Rein Therapeutics | 01/10/2025 |
About Aileron Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Aileron or other delisted stocks. Alpha measures the amount that position in Aileron Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Aileron Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of Aileron Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aileron Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Aileron Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Aileron Therapeutics. Please utilize our Beneish M Score to check the likelihood of Aileron Therapeutics' management manipulating its earnings.
| 18th of March 2024 Upcoming Quarterly Report | View | |
| 13th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 18th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Aileron Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Aileron Stock
If you are still planning to invest in Aileron Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aileron Therapeutics' history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets |